Results for tag: "Gram Positive Bacterial Infection Drug"

The Gram Positive Bacterial Infection Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat infections caused by Gram-positive bacteria, which are bacteria that retain the crystal violet dye when treated with a Gram stain. These drugs are typically antibiotics, such as penicillins, cephalosporins, macrolides, and glycopeptides. They are used to treat a variety of infections, including skin and soft tissue infections, respiratory tract infections, and endocarditis. The Gram Positive Bacterial Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. Show Less Read more